Form 4: Cintas Director Receives Equity Grant
Insider Equity Grant Disclosure
Cintas Corporation's Director, Karen L. Carnahan, was granted 503 restricted shares and 1,694 stock options as part of the company's equity compensation plan.
Summary
- Karen L. Carnahan, a Director of Cintas Corp (CTAS), reported the acquisition of 503 shares of Common Stock on October 29, 2025.
- These 503 shares are restricted shares granted under Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan, with a grant price of $0.
- The restricted shares will cliff vest on the first anniversary of the grant date.
- Following this transaction, Karen L. Carnahan beneficially owns 25,256 shares of Common Stock.
- Additionally, Karen L. Carnahan was granted 1,694 stock options (right to buy) on October 29, 2025, with an exercise price of $183.9 per share.
- These options were also granted under the 2016 Amended and Restated Equity and Incentive Compensation Plan, with a price of $0 for the derivative security.
- The stock options will cliff vest on the first anniversary of the grant date and have an expiration date of October 29, 2035.
- Following this transaction, Karen L. Carnahan beneficially owns 1,694 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The filing indicates a routine equity grant to a director, which is a positive for aligning management and shareholder interests. It is not a significant market-moving event but reflects standard corporate compensation practices.
Positives
- The equity grants align the interests of Director Karen L. Carnahan with those of Cintas Corporation's shareholders, promoting long-term value creation.
- The grants are part of a pre-existing, approved equity compensation plan (2016 Amended and Restated Equity and Incentive Compensation Plan), indicating structured governance around executive and director incentives.
Future Outlook
The restricted shares and stock options granted to Director Carnahan are set to cliff vest on the first anniversary of the grant date, aligning her future compensation with the company's performance over the coming year.
Industry Context
The granting of restricted stock and stock options to directors is a common practice across publicly traded companies, serving as a key component of director compensation to incentivize long-term commitment and align leadership interests with shareholder value.
Comparison to Industry Standards
- Equity compensation for directors, including restricted stock and stock options, is a standard practice in corporate governance across various industries, including the business services sector where Cintas operates.
- While specific comparable companies and their exact grant sizes are not detailed in this filing, the structure of granting performance-based equity is consistent with global benchmarks for director remuneration aimed at fostering long-term alignment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The equity grants were made pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan, demonstrating the ongoing use of an established governance framework for executive and director compensation. | 10/29/2025 | Reinforces the company's commitment to performance-based compensation and aligns director incentives with long-term shareholder value. |
Related Party Transactions
- Grant of equity awards (503 restricted shares and 1,694 stock options) to Karen L. Carnahan, a Director of Cintas Corporation, which constitutes a related-party compensation transaction.
Stakeholder Impact
- Shareholders: The equity grants aim to align the director's long-term interests with shareholder value creation.
- Management: The grants are part of the company's incentive structure for its leadership.
Next Steps
- The restricted shares and stock options will vest on the first anniversary of the grant date (October 29, 2026).
Key Dates
| Date | Description |
|---|---|
| 10/29/2025 | Transaction Date for acquisition of 503 restricted shares and 1,694 stock options. |
| 10/29/2026 | Estimated vesting date for both restricted shares and stock options (first anniversary of grant date). |
| 10/29/2035 | Expiration date for the granted stock options. |
| 10/31/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Cintas, CTAS, Form 4, Insider Transaction, Equity Grant, Stock Options, Restricted Stock, Director Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.